Dashboard
1
High Management Efficiency with a high ROE of 10.63%
2
Company has very low debt and has enough cash to service the debt requirements
3
Flat results in Jun 25
4
With ROE of 10.15%, it has a very attractive valuation with a 1.46 Price to Book Value
5
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 265,741 Million (Small Cap)
14.00
NA
0.01%
-0.36
10.61%
1.55
Revenue and Profits:
Net Sales:
30,376 Million
(Quarterly Results - Jun 2025)
Net Profit:
2,829 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.43%
0%
-0.43%
6 Months
1.02%
0%
1.02%
1 Year
-0.72%
0%
-0.72%
2 Years
3.59%
0%
3.59%
3 Years
66.95%
0%
66.95%
4 Years
-18.59%
0%
-18.59%
5 Years
-8.1%
0%
-8.1%
Fukuda Denshi Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.83%
EBIT Growth (5y)
14.26%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
31.41%
Dividend Payout Ratio
30.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.46%
ROE (avg)
10.63%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.46
EV to EBIT
7.52
EV to EBITDA
5.34
EV to Capital Employed
1.75
EV to Sales
1.40
PEG Ratio
NA
Dividend Yield
0.01%
ROCE (Latest)
23.25%
ROE (Latest)
10.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
30,376.00
30,341.00
0.12%
Operating Profit (PBDIT) excl Other Income
6,959.00
7,051.00
-1.30%
Interest
14.00
9.00
55.56%
Exceptional Items
5.00
-4.00
225.00%
Consolidate Net Profit
2,829.00
3,031.00
-6.66%
Operating Profit Margin (Excl OI)
137.60%
148.80%
-1.12%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 0.12% vs 3.98% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -6.66% vs -13.28% in Jun 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
139,007.00
140,323.00
-0.94%
Operating Profit (PBDIT) excl Other Income
36,424.00
36,232.00
0.53%
Interest
50.00
34.00
47.06%
Exceptional Items
231.00
2.00
11,450.00%
Consolidate Net Profit
18,605.00
18,693.00
-0.47%
Operating Profit Margin (Excl OI)
186.10%
188.90%
-0.28%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is -0.94% vs 4.21% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -0.47% vs 8.19% in Mar 2024
About Fukuda Denshi Co., Ltd. 
Fukuda Denshi Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






